Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Daly

Showing results (351-360 of 511) with videos related to

Pageof 52
Sort By:
Cancer Research|September 10, 2009
A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesisPål Saetrom, Jacob Biesinger, Sierra M Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesisSiddharth Banka, Stuart A Cain, Sabrya Carim, et al.
Neurology|December 7, 2014
Mutations in LZTR1 add to the complex heterogeneity of schwannomatosisMiriam J Smith, Bertand Isidor, Christian Beetz, et al.
Pharmaceutics|December 23, 2023
Pharmacokinetic Study of Islatravir and Etonogestrel Implants in MacaquesMichele B Daly, Andres Wong-Sam, Linying Li, et al.
American Journal of Human Genetics|June 22, 2010
Mutations in HPSE2 cause urofacial syndromeSarah B Daly, Jill E Urquhart, Emma Hilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2025
A subcutaneous implant that releases islatravir provides long-lasting protection against vaginal SHIV infection in macaquesMichele B Daly, Daniel Kim, Archana Krovi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.
Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.
Pageof 52

Showing results (351-360 of 511) with videos related to

Sort By:
Pageof 52
Cancer Research|September 10, 2009
A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesisPål Saetrom, Jacob Biesinger, Sierra M Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesisSiddharth Banka, Stuart A Cain, Sabrya Carim, et al.
Neurology|December 7, 2014
Mutations in LZTR1 add to the complex heterogeneity of schwannomatosisMiriam J Smith, Bertand Isidor, Christian Beetz, et al.
Pharmaceutics|December 23, 2023
Pharmacokinetic Study of Islatravir and Etonogestrel Implants in MacaquesMichele B Daly, Andres Wong-Sam, Linying Li, et al.
American Journal of Human Genetics|June 22, 2010
Mutations in HPSE2 cause urofacial syndromeSarah B Daly, Jill E Urquhart, Emma Hilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2025
A subcutaneous implant that releases islatravir provides long-lasting protection against vaginal SHIV infection in macaquesMichele B Daly, Daniel Kim, Archana Krovi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.
Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.
Pageof 52